Brunton, a 41-year-old Remuera software accountant, has been battling an aggressive form of blood cancer since January. About a month ago his condition escalated dramatically, spreading to five tumours around his body.
Brunton had been officially accepted onto the CAR-T trial this morning and would commence treatment on September 19.
The process would involve harvesting Brunton's T-cells, which would spend three to four weeks being genetically engineered before being reintroduced.